Puma Biotechnology reported $97.68M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 35705M 305M
Biogen BIIB:US $ 6277.4M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Clovis Oncology CLVS:US $ 621.38M 7.38M
Daiichi Sankyo 4568:JP Y 142973M 94M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Glaxosmithkline GSK:US $ 18784M 10442M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 641M 5M
Novartis NOVN:VX SF 23784M 589M
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Takeda 4502:JP Y 4320357M 178939M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 31.16M 0.23M